Skip to content

Clinical trials

Phase 3 Hypercholesterolemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypercholesterolemia Phase: Phase 3 Country / region: United States Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20042
20056
20063
20076
20087
20093
20101
20112
201210
201314
20142
20152
20168
20174
20183
20191
20201
20217
20223
20235
20244
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79
Terminated11
Recruiting5
Active, not recruiting4
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen18
Sanofi15
Novartis Pharmaceuticals8
Takeda8
AstraZeneca7
Esperion Therapeutics, Inc.6
Kastle Therapeutics, LLC5
LIB Therapeutics LLC5
Merck Sharp & Dohme LLC5
Regeneron Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypercholesterolemia102
Hyperlipidemias29
Dyslipidemias22
Hyperlipoproteinemia Type II16
Atherosclerosis14
Cardiovascular Diseases9
Homozygous Familial Hypercholesterolemia6
Coronary Disease5
Diabetes Mellitus4
Genetic Diseases, Inborn4

Trials

Showing 1 to 25 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.